ChemChina has offered to acquire Syngenta at US$465 per ordinarynow magnesium citrate tablets share plus a special dividend of CHF5 (US$5.03) to beferrous gluconate 320 mg paid conditional upon and prior to closing. The offer is equivalent to a Swiss franc value of CHF480 per share.###Syngenta shareholders will in addition receive the proposed ordinary dividend of CHF 11 in May 2016.###It is planned to make a facility available for the conversion of US dollar sales proceedscitracal kosher into Swiss francs on closing.###Syngenta’s existing management will continue to run the company.###After closing, a 10-member Board of Directors wiferritin fumaratell be chaired by Ren Jianxin, chairman of ChemChina, and will include four of the existing Syngenta Board members.###“The transaction minimizes operational disruption; it is focused on growth globally, specifically in China and other emerging markets, and enables long-term investment in innovation,” said Michel Demaré, chairman of Syngenta.###“Syngenta will continue to be headquartered in Switzerland.”###The transaction will enable funature’s blend ferrous gluconaterther expansion of Syngenta’s presence in emerging markets and notably in China.